------ =_NextPart_000_01BCDB1F.B1EB7AC0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable
This is the drug the neurologist started my mother on. Over the last =
two years, she has tried Sinnemet, Artance, Requip, and Permax. Eeach =
time she goes back to the Artane and Permax combination. Very expensive =
drug though. She starts slowing down about 1 hour before dose time. =
She takes Permax at 7 A, 1 P, and 7 P.
Becky Hunt, CG of Mom, 73/2, Sedalia, Missouri, USA
[log in to unmask]
----------
From: WHITIE[SMTP:[log in to unmask]]
Sent: Friday, October 17, 1997 5:47 AM
To: Multiple recipients of list PARKINSN
Subject: Permax questions
Hi all ;
My mother just started PERMAX at one 0.05 mg. a day, can anyone tell me
if they are using permax, and if it helps much ?
she also takes 3- SINEMET CR 25/100 a day spaced at about 4 hours.
The new neuro that rx'd it, said it will help with, getting up from a =
chair, and
with the walking problem. I asked for mirapex, but he thinks permax will =
work
better on the walking problems. WHITIE
[log in to unmask]
------ =_NextPart_000_01BCDB1F.B1EB7AC0
Content-Type: application/ms-tnef
Content-Transfer-Encoding: base64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------ =_NextPart_000_01BCDB1F.B1EB7AC0--
